EE9900566A - Helicobacter pylori FlgE polüpeptiidi sisaldavad vaktsiinikoostised - Google Patents
Helicobacter pylori FlgE polüpeptiidi sisaldavad vaktsiinikoostisedInfo
- Publication number
- EE9900566A EE9900566A EEP199900566A EEP9900566A EE9900566A EE 9900566 A EE9900566 A EE 9900566A EE P199900566 A EEP199900566 A EE P199900566A EE P9900566 A EEP9900566 A EE P9900566A EE 9900566 A EE9900566 A EE 9900566A
- Authority
- EE
- Estonia
- Prior art keywords
- compositions containing
- helicobacter pylori
- vaccine compositions
- containing helicobacter
- flge polypeptide
- Prior art date
Links
- 241000590002 Helicobacter pylori Species 0.000 title 1
- 229940037467 helicobacter pylori Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56922—Campylobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702242A SE9702242D0 (sv) | 1997-06-12 | 1997-06-12 | Vaccine compositions V |
| PCT/SE1998/001093 WO1998056816A1 (en) | 1997-06-12 | 1998-06-08 | VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9900566A true EE9900566A (et) | 2000-06-15 |
Family
ID=20407351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP199900566A EE9900566A (et) | 1997-06-12 | 1998-06-08 | Helicobacter pylori FlgE polüpeptiidi sisaldavad vaktsiinikoostised |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1009764A1 (et) |
| JP (1) | JP2002507118A (et) |
| KR (1) | KR20010013699A (et) |
| CN (1) | CN1259960A (et) |
| AR (1) | AR012896A1 (et) |
| AU (1) | AU8048798A (et) |
| BR (1) | BR9810026A (et) |
| CA (1) | CA2293293A1 (et) |
| EE (1) | EE9900566A (et) |
| HU (1) | HUP0003164A3 (et) |
| ID (1) | ID23052A (et) |
| IL (1) | IL133144A0 (et) |
| IS (1) | IS5288A (et) |
| NO (1) | NO996132L (et) |
| NZ (1) | NZ501427A (et) |
| PL (1) | PL337503A1 (et) |
| SE (1) | SE9702242D0 (et) |
| SK (1) | SK173099A3 (et) |
| TR (1) | TR199903060T2 (et) |
| WO (1) | WO1998056816A1 (et) |
| ZA (1) | ZA984696B (et) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104784687A (zh) * | 2015-04-27 | 2015-07-22 | 苏州大学附属第一医院 | 重组绿脓杆菌鞭毛钩蛋白FlgE的用途 |
| CN113425717B (zh) * | 2021-04-22 | 2023-06-16 | 成都欧林生物科技股份有限公司 | 一种提高口服幽门螺杆菌疫苗效力的药剂及其应用 |
| CN116535472B (zh) * | 2023-05-31 | 2024-04-30 | 四川大学华西医院 | 一种幽门螺杆菌重组蛋白抗原FlgK及其制备方法与应用 |
| CN118105473B (zh) * | 2024-04-30 | 2024-08-16 | 成都欧林生物科技股份有限公司 | 一种预防或治疗Hp感染口服免疫原性组合物及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5459041A (en) * | 1988-02-18 | 1995-10-17 | Enteric Research Laboratories, Inc. | Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection |
| AR003125A1 (es) * | 1995-06-01 | 1998-07-08 | Astra Ab | Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la |
-
1997
- 1997-06-12 SE SE9702242A patent/SE9702242D0/xx unknown
-
1998
- 1998-06-01 AR ARP980102558A patent/AR012896A1/es unknown
- 1998-06-01 ZA ZA984696A patent/ZA984696B/xx unknown
- 1998-06-08 KR KR1019997011714A patent/KR20010013699A/ko not_active Application Discontinuation
- 1998-06-08 HU HU0003164A patent/HUP0003164A3/hu unknown
- 1998-06-08 AU AU80487/98A patent/AU8048798A/en not_active Abandoned
- 1998-06-08 TR TR1999/03060T patent/TR199903060T2/xx unknown
- 1998-06-08 CN CN98806101A patent/CN1259960A/zh active Pending
- 1998-06-08 ID IDW991542A patent/ID23052A/id unknown
- 1998-06-08 EP EP98928772A patent/EP1009764A1/en not_active Withdrawn
- 1998-06-08 NZ NZ501427A patent/NZ501427A/xx unknown
- 1998-06-08 EE EEP199900566A patent/EE9900566A/et unknown
- 1998-06-08 JP JP50228399A patent/JP2002507118A/ja active Pending
- 1998-06-08 WO PCT/SE1998/001093 patent/WO1998056816A1/en not_active Application Discontinuation
- 1998-06-08 BR BR9810026-2A patent/BR9810026A/pt not_active IP Right Cessation
- 1998-06-08 SK SK1730-99A patent/SK173099A3/sk unknown
- 1998-06-08 IL IL13314498A patent/IL133144A0/xx unknown
- 1998-06-08 CA CA002293293A patent/CA2293293A1/en not_active Abandoned
- 1998-06-08 PL PL98337503A patent/PL337503A1/xx unknown
-
1999
- 1999-12-08 IS IS5288A patent/IS5288A/is unknown
- 1999-12-10 NO NO996132A patent/NO996132L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0003164A2 (hu) | 2000-12-28 |
| IL133144A0 (en) | 2001-03-19 |
| SE9702242D0 (sv) | 1997-06-12 |
| AU8048798A (en) | 1998-12-30 |
| BR9810026A (pt) | 2000-09-19 |
| TR199903060T2 (xx) | 2000-09-21 |
| NO996132D0 (no) | 1999-12-10 |
| KR20010013699A (ko) | 2001-02-26 |
| HUP0003164A3 (en) | 2001-10-29 |
| PL337503A1 (en) | 2000-08-28 |
| CA2293293A1 (en) | 1998-12-17 |
| EP1009764A1 (en) | 2000-06-21 |
| JP2002507118A (ja) | 2002-03-05 |
| ZA984696B (en) | 1999-01-04 |
| ID23052A (id) | 2000-01-20 |
| SK173099A3 (en) | 2000-06-12 |
| WO1998056816A1 (en) | 1998-12-17 |
| CN1259960A (zh) | 2000-07-12 |
| NZ501427A (en) | 2000-09-29 |
| AR012896A1 (es) | 2000-11-22 |
| NO996132L (no) | 2000-01-28 |
| IS5288A (is) | 1999-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE04481B1 (et) | Peptiididel ja adjuvantidel baseeruv farmatseutiline kompositsioon immuunmodulatsiooni jaoks | |
| IL142216A0 (en) | A polypeptide containing an immunogenic portion of a native wti and pharmaceutical compositions containing the same | |
| NO20001914D0 (no) | <alfa>-Aryl-N-alkylnitroner og farmasøytiske blandinger som inneholder slike | |
| NO996133D0 (no) | Olje-i-vann-vaksinesammensetninger | |
| NO975490D0 (no) | Heliobacter pylori antigener og vaksinesammensetninger | |
| NO20003303L (no) | Vaksine | |
| DE69717853D1 (de) | Verpacktes lichthärtbares gemisch | |
| FR2746302B1 (fr) | Compositions cosmetiques comprenant des nanopigments | |
| NO995891L (no) | LH-RH peptidanaloger, anvendelser og farmasoeytiske blandinger inneholdende disse | |
| ID17860A (id) | Komposisi vaksin | |
| DE69725482D1 (de) | Härtbare Siliconzusammensetzungen | |
| EP0998942A4 (en) | METHOD FOR STABILIZING PEPTIDES AND FREEZERED MEDICINAL COMPOSITIONS THEREOF | |
| EE9800334A (et) | Helicobacter pylor' iga seotud nukleiinhapete ja aminohapete järjestused ja nendest tuletatud vaktsiinikompositsioonid | |
| DE69726068D1 (de) | Härtbare Polymethylsilsesquioxanzusammensetzung | |
| EE9800400A (et) | Diklofenaaki sisaldavad farmatseutilised kompositsioonid | |
| PT925273E (pt) | Composicoes farmaceuticas contendo acidos 4-oxobutanoicos | |
| BR9708248A (pt) | Benzotiofenos formulações contendo os mesmos e metódos | |
| BR9707657A (pt) | Benzotiofenos formulações contendo os mesmos e métodos | |
| NO995039D0 (no) | Gastrisk bibeholdt farmasöytisk preparat | |
| AU1698699A (en) | (helicobacter pylori) vaccine formulations | |
| DE69804573D1 (de) | Organopolysiloxan-Zusammensetzungen | |
| EE9900566A (et) | Helicobacter pylori FlgE polüpeptiidi sisaldavad vaktsiinikoostised | |
| EE03511B1 (et) | Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid | |
| DK1222921T3 (da) | Farmaceutiske sammensætninger indeholdende tizoxanid og/eller nitazoxanid | |
| ATE295182T1 (de) | Zusammensetzungen zur immunverstärkung von impfstoffen |